These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11817766)

  • 21. Abstinence-related changes in sleep during treatment for cocaine dependence.
    Angarita GA; Canavan SV; Forselius E; Bessette A; Pittman B; Morgan PT
    Drug Alcohol Depend; 2014 Jan; 134():343-347. PubMed ID: 24315572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence.
    Viola TW; Tractenberg SG; Wearick-Silva LE; Rosa CS; Pezzi JC; Grassi-Oliveira R
    Drug Alcohol Depend; 2014 Nov; 144():153-9. PubMed ID: 25262527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence.
    Kampman K; Majewska MD; Tourian K; Dackis C; Cornish J; Poole S; O'Brien C
    Addict Behav; 2003 Apr; 28(3):437-48. PubMed ID: 12628617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot trial of olanzapine for the treatment of cocaine dependence.
    Kampman KM; Pettinati H; Lynch KG; Sparkman T; O'Brien CP
    Drug Alcohol Depend; 2003 Jun; 70(3):265-73. PubMed ID: 12757964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials.
    Bashiri M; Mancino MJ; Stanick VA; Thostenson J; Kosten TR; Oliveto AH
    Am J Addict; 2017 Dec; 26(8):807-814. PubMed ID: 29115703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.
    Schmitz JM; Green CE; Stotts AL; Lindsay JA; Rathnayaka NS; Grabowski J; Moeller FG
    Drug Alcohol Depend; 2014 Mar; 136():100-7. PubMed ID: 24424425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.
    Levin FR; Bisaga A; Raby W; Aharonovich E; Rubin E; Mariani J; Brooks DJ; Garawi F; Nunes EV
    J Subst Abuse Treat; 2008 Jan; 34(1):80-9. PubMed ID: 17574796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mazindol treatment for cocaine dependence.
    Stine SM; Krystal JH; Kosten TR; Charney DS
    Drug Alcohol Depend; 1995 Oct; 39(3):245-52. PubMed ID: 8556974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
    Sofuoglu M; Gonzalez G; Poling J; Kosten TR
    Am J Drug Alcohol Abuse; 2003; 29(4):713-27. PubMed ID: 14713135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence.
    Alterman AI; Kampman K; Boardman CR; Cacciola JS; Rutherford MJ; McKay JR; Maany I
    Drug Alcohol Depend; 1997 Jun; 46(1-2):79-85. PubMed ID: 9246555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Plebani JG; Pettinati HM; Sparkman T; O'Brien CP
    J Subst Abuse Treat; 2012 Oct; 43(3):303-12. PubMed ID: 22377391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
    Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
    Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients.
    Winstanley EL; Bigelow GE; Silverman K; Johnson RE; Strain EC
    J Subst Abuse Treat; 2011 Apr; 40(3):255-64. PubMed ID: 21266301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trial of modafinil for cocaine dependence.
    Umanoff DF
    Neuropsychopharmacology; 2005 Dec; 30(12):2298; author reply 2299-300. PubMed ID: 16294193
    [No Abstract]   [Full Text] [Related]  

  • 36. The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day.
    Somoza E; Somoza P; Lewis D; Li SH; Winhusen T; Chiang N; Vocci F; Horn P; Elkashef A
    Drug Alcohol Depend; 2008 Jan; 93(1-2):132-40. PubMed ID: 18029115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modafinil for the treatment of cocaine dependence.
    Anderson AL; Reid MS; Li SH; Holmes T; Shemanski L; Slee A; Smith EV; Kahn R; Chiang N; Vocci F; Ciraulo D; Dackis C; Roache JD; Salloum IM; Somoza E; Urschel HC; Elkashef AM
    Drug Alcohol Depend; 2009 Sep; 104(1-2):133-9. PubMed ID: 19560290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of the dopaminergic agent, phentermine, and the serotonergic agent, fenfluramine, in the treatment of cocaine dependence.
    Kampman KM; Volpicelli J
    J Subst Abuse Treat; 1997; 14(4):401-4. PubMed ID: 9368218
    [No Abstract]   [Full Text] [Related]  

  • 39. A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment.
    Crist RC; Doyle GA; Kampman KM; Berrettini WH
    Drug Alcohol Depend; 2016 Sep; 166():268-71. PubMed ID: 27449273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.
    Reid MS; Casadonte P; Baker S; Sanfilipo M; Braunstein D; Hitzemann R; Montgomery A; Majewska D; Robinson J; Rotrosen J
    Addiction; 2005 Mar; 100 Suppl 1():43-57. PubMed ID: 15730349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.